Established in 1995 by two veterans of the pharmaceutical industry, Synteract is a privately held, full-service contract research organization, dedicated to meeting the clinical research, technology, and safety needs of biotechnology, medical device, and pharmaceutical companies. Our mission is to provide high quality yet personal service, working closely with drug and device sponsors as though we were a department within your company. Headquartered in Carlsbad, California, with a branch office in North Carolina, we provide expertise in a wide range of therapeutic areas in clinical trials, including a strong emphasis in oncology, central nervous system (CNS), cardiovascular disease, and ophthalmology. Synteract currently employs over 230 professionals in its two offices and regionally throughout the U.S. Additionally, we have partnered with key international firms in order to provide outstanding patient cost and time-to-enrollment advantages in regions such as Eastern and Western Europe, Australia, India, and Brazil. The company vows to continue its focus on meeting the specific needs of emerging drug, device and biotechnology firms, by providing motivated and experienced staff, customized solutions, quality deliverables, and sound regulatory compliance. In doing this, Synteract truly commits to each project, embracing our corporate philosophy of “Shared Work, Shared Vision.” www.synteract.com FGK Clinical Research GmbH Heimeranstrasse 35 80339 Munich Germany T | +49 (0) 89 893 119-0 F | +49 (0) 89 893 119-20 www.fgk-cro.com info@fgk-cro.com